Kymab
HealthTech,News,Venture Capital
ORI Capital exits investment in Kymab to Sanofi in a $1.1B deal, announces upcoming $400M ORI Fund II
Hong Kong-based healthcare fund management firm ORI Capital has decided to exit Kymab, a British biopharmaceutical company that specializes in vaccines and novel drug solutions.…
January 14, 2021
Temasek participates in US’s EV battery maker ONE $300M funding
February 3, 2023
Grab appoints Adelene Foo as Managing Director of Grab Malaysia
February 3, 2023
Temasek participates in US’s EV battery maker ONE $300M funding
February 3, 2023
Grab appoints Adelene Foo as Managing Director of Grab Malaysia
February 3, 2023